Carol Ann Satler
Präsident bei Respira Therapeutics, Inc.
Profil
Carol Ann Satler is currently the President, Director, and Chief Medical Officer at Respira Therapeutics, Inc. She was previously the President and Chief Executive Officer at Indigo Pharmaceuticals, Inc. She holds a doctorate degree from Case Western Reserve University and an undergraduate degree from Wesleyan University.
Aktive Positionen von Carol Ann Satler
Unternehmen | Position | Beginn |
---|---|---|
Respira Therapeutics, Inc.
Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM. | Präsident | - |
Ehemalige bekannte Positionen von Carol Ann Satler
Unternehmen | Position | Ende |
---|---|---|
Indigo Pharmaceuticals, Inc.
Indigo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indigo Pharmaceuticals, Inc. manufactures pharmaceutical products. It mainly focuses on the development of new treatments for cardiovascular diseases, such as peripheral arterial disease. The company was founded in 2007 and is headquartered in New York, NY. | Vorstandsvorsitzender | - |
Ausbildung von Carol Ann Satler
Case Western Reserve University | Doctorate Degree |
Wesleyan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Indigo Pharmaceuticals, Inc.
Indigo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indigo Pharmaceuticals, Inc. manufactures pharmaceutical products. It mainly focuses on the development of new treatments for cardiovascular diseases, such as peripheral arterial disease. The company was founded in 2007 and is headquartered in New York, NY. | Health Technology |
Respira Therapeutics, Inc.
Respira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Respira Therapeutics, Inc. engages in provision of pulmonary delivery of therapeutics for respiratory diseases. Its technology Dry Powder Inhaler (DPI), deliver dry powder drug products to the lung more effectively than other DPI technologies. The company was founded in 2010 and is headquartered in Albuquerque, NM. | Health Technology |